NWBO Northwest Biotherapeutics, Inc.

$0.19

Northwest Biotherapeutics, Inc. (NWBO) is expected to report earnings on November 13, 2026, after the market close.

Northwest Biotherapeutics Reported Earnings
Earnings Date
Nov 13
Friday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics Inc is a development stage biotechnology company engaged in the development of immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies.

Sector

Healthcare